CCL2 and lung cancer: In early-stage lung cancer nodules and metastatic lung cancer, IGFBP7+PLVAP+ tumor ECs were greatly amplified, whereas the proportion of extra-alveolar capillary ECs (cECs), EDN1+CCL2+ ECs, decreased.